AbbVie Inc

NYSE:ABBVHealthcareCBOE:SPESGNASDAQ:NQUSLG

$282.74−0.94%At closeAt close · Mon 19 Oct · ≈ AED 1,038.36 · Market cap $499.63B · Next earnings Fri 30 Oct · Extended $282.84 +0.04%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	66.4%	69.0%	70.0%	62.4%	70.0%	70.2%	—	—
Operating margin	24.8%	31.9%	31.2%	23.5%	16.2%	32.8%	32.8%	+0.0 pts
Net margin	10.1%	20.5%	20.4%	9.0%	7.6%	6.9%	6.9%	+0.0 pts
EBITDA margin	26.9%	42.6%	41.6%	31.6%	26.5%	28.8%	—	—
Return on equity	35.3%	74.9%	68.6%	46.9%	128.7%	−129.2%	−130.9%	−1.7 pts
Return on assets	3.1%	7.9%	8.5%	3.6%	3.2%	3.2%	3.2%	+0.0 pts
Return on capital employed	9.3%	16.1%	16.6%	13.2%	9.5%	22.2%	—	—
Debt / equity	6.7×	5.0×	3.7×	5.8×	20.4×	−21.1×	−21.4×	−1.3%
Debt / assets	57.8%	52.9%	46.2%	44.6%	50.2%	51.6%	—	—
Interest coverage	4.6×	7.4×	8.1×	5.7×	3.3×	6.9×	—	—
Current ratio	0.8×	0.8×	1.0×	0.9×	0.7×	0.7×	0.7×	+0.0%
Quick ratio	0.7×	0.7×	0.8×	0.8×	0.6×	0.6×	—	—
Cash ratio	0.3×	0.3×	0.3×	0.3×	0.1×	0.1×	0.1×	+0.0%
Asset turnover	0.3×	0.4×	0.4×	0.4×	0.4×	0.5×	—	—
Inventory turnover	4.6×	5.6×	4.9×	5.0×	4.0×	3.7×	—	—
Receivables turnover	5.2×	5.6×	5.2×	4.9×	5.2×	4.9×	—	—
Dividend payout	167.2%	80.2%	84.9%	216.7%	257.7%	275.8%	—	—